Navigation Links
PAREXEL Experts to Address Partnering Best Practices and Innovative Trial Design at Partnerships With CROs Conference
Date:4/22/2009

in that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "targets," and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business, including, but not limited to, the successful business integration and anticipated synergy achievements in connection with the ClinPhone acquisition; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the q
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. PAREXEL International to Present at Bank of America 2008 Smid Cap Conference
2. PAREXEL International to Present at Robert W. Bairds 2008 Growth Stock Conference
3. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
4. PAREXEL International to Present at NASDAQ OMX 22nd Investor Program
5. PAREXEL Reports Preliminary Second Quarter Results
6. PAREXEL Announces Date of Second Quarter Fiscal Year 2009 Earnings Release and Conference Call
7. PAREXEL Reports Second Quarter Fiscal Year 2009 Financial Results
8. PAREXEL Consulting Enhances European Regulatory Affairs Capabilities With Appointment of Medical Products Agency Expert Dr. Anders Neil
9. PAREXEL International to Present at Raymond James 30th Annual Institutional Investors and the Barclays Capital Global Healthcare Conferences
10. PAREXEL Announces Date of Third Quarter Fiscal Year 2009 Earnings Release and Conference Call
11. Research Links TV/Video Game Playing With Child Obesity; Health Experts Back a New Approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... Rise of Local Food,” scheduled for Nov. 3 – 4, 2015, at UC ... food sustainably, create new businesses, improve food access, and manage resources efficiently against ...
(Date:8/4/2015)... ... 2015 , ... Many men are confused about the safety of testosterone replacement ... as a voice of authority for men seeking accurate information about testosterone. , ... and expertise in the safe and effective treatment of low testosterone. In recent years, ...
(Date:8/4/2015)... ... August 04, 2015 , ... They say a picture ... certain health conditions, pictures and medical art can be essential. StayWell, a health solutions ... , Krames Patient Education solutions have been used by physicians and other health care ...
(Date:8/4/2015)... ... August 04, 2015 , ... Discovia, a ... today announced that John Munro, a 15-year veteran of the eDiscovery services industry, ... Operations. , “I am thrilled to join Discovia at this important point in ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... consultation complete with full examination now offered by the world renowned Beverly ... beautiful aesthetic facial appearance through cosmetic surgery techniques helps individuals to achieve an ...
Breaking Medicine News(10 mins):Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3
... Business Coalition on Health releases nationwide eValue8,findings, ... to the eValue8,(TM) report of health plan ... Coalition on Health (NBCH), health plans could ... with their customers, enabling,improvements in patient safety, ...
... Nicotine Cessation Expert and ... Former ... just a,habit; it,s an addiction. Hazelden has been helping alcoholics and ... principles,of the Hazelden treatment experience help tobacco users find recovery, too. ...
... University Hospitals Case Medical Center finds that Deep ... Tourette Syndrome (TS). This first-of-its-kind study of five ... tic frequency and severity in some people who ... is a neurobehavioral disorder characterized by sudden, repetitive ...
... kill them, study finds , , MONDAY, Nov. 12 (HealthDay ... weapons that helps make community-associated methicillin-resistant Staphylococcus aureus ... be done, the study "provides a partial explanation of ... and gives a starting point in the development of ...
... dental mercury uses contribute to high mercury,levels in fish ... first time, that dental mercury air,emissions may be more ... WASHINGTON, Nov.12 The U.S. House,Subcommittee on Domestic ... a hearing on Wednesday, Nov. 14, to discuss FDA,s,responsibility ...
... Gov. Mitch,Daniels joined executives from Medco Health Solutions, ... company,s plans to build the world,s largest and ... growing,nationwide demand for lower-cost medicines. The new 318,000-square-foot,pharmacy, ... an area equivalent to,six and a half football ...
Cached Medicine News:Health News:National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety 2Health News:National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety 3Health News:National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety 4Health News:Quit Smoking Tips For The Great American Smokeout Day - November 15 2Health News:University Hospitals Case Medical Center finds new treatment holds promise for Tourette syndrome 2Health News:University Hospitals Case Medical Center finds new treatment holds promise for Tourette syndrome 3Health News:Key to MRSA Virulence in Community Discovered 2Health News:Key to MRSA Virulence in Community Discovered 3Health News:Environmental Impacts of Dental Mercury Focus of U.S. House Oversight Hearing Wednesday 2Health News:Medco to Build World's Largest, Most Advanced Automated Pharmacy in Central Indiana 2Health News:Medco to Build World's Largest, Most Advanced Automated Pharmacy in Central Indiana 3Health News:Medco to Build World's Largest, Most Advanced Automated Pharmacy in Central Indiana 4Health News:Medco to Build World's Largest, Most Advanced Automated Pharmacy in Central Indiana 5
(Date:8/4/2015)... LOS ANGELES , Aug. 4, ... ), the world,s leading provider of diagnostic information ... previously announced acquisition of MemorialCare Health System,s laboratory ... result of the transaction, patients and physicians now ... services and network of nearly 200 patient service ...
(Date:8/4/2015)... 2015  The Pittsburgh Life Sciences Greenhouse (PLSG), the ... that one of its portfolio companies, Medrobotics Corporation, has ... Robotic System in the U.S.  ... Medrobotics," said John W. Manzetti , president and ... way since spinning out of The Robotics Institute at ...
(Date:8/4/2015)... Calif., Aug. 4, 2015  Isis Pharmaceuticals, Inc. (Nasdaq: ... million and $18.9 million for the three and six ... net loss of $12.1 million and $43.4 million for ... results were driven primarily by the more than $90 ... related to the upfront payment from Bayer to license  ...
Breaking Medicine Technology:Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
... 2012  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the ... a company overview at Citi,s 2012 Global Health Care Conference ... the Waldorf Astoria in New York City. A ... the "Investors & Media" section of the Company,s Web site, ...
... Feb. 21, 2012   Enanta Pharmaceuticals, Inc. , ... best-in-class small molecule drugs in the infectious disease ... an exclusive collaboration and license agreement with Novartis ... its lead development candidate, EDP-239, from its NS5A ...
Cached Medicine Technology:Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 2Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 3
... Healthcare is known as ... analysis programs for every ... device. With advanced programs ... and ACI-TIPI, GE can ...
... The Affinity pacemaker family ... smallest, truly automatic devices. ... combination of advanced technologies ... DR pacemaker incorporates the ...
... Guidant INSIGNIA Ultra pacing ... easy-to-use features for simplified ... patient safety. All INSIGNIA ... using the ZOOM Programming ...
... SDX model 1688 and model 1488 active-fixation ... pacing leads, offering the unsurpassed handling advantages, ... Medical's line of active-fixation leads. Implantable with ... diameter of the Tendril SDX lead is ...
Medicine Products: